According to a survey conducted in India, the share of overweight or obese women increased from **** percent in 2016 to ** percent in 2021. On the other hand, the prevalence among men increased to about **** percent in 2021.

India IN: Prevalence of Overweight: Weight for Height: % of Children Under 5, Modeled Estimate data was reported at 3.700 % in 2024. This records an increase from the previous number of 3.400 % for 2023. India IN: Prevalence of Overweight: Weight for Height: % of Children Under 5, Modeled Estimate data is updated yearly, averaging 2.300 % from Dec 2000 (Median) to 2024, with 25 observations. The data reached an all-time high of 3.700 % in 2024 and a record low of 2.100 % in 2013. India IN: Prevalence of Overweight: Weight for Height: % of Children Under 5, Modeled Estimate data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s India – Table IN.World Bank.WDI: Social: Health Statistics. Prevalence of overweight children is the percentage of children under age 5 whose weight for height is more than two standard deviations above the median for the international reference population of the corresponding age as established by the WHO's 2006 Child Growth Standards.;UNICEF, WHO, World Bank: Joint child Malnutrition Estimates (JME).;Weighted average;Once considered only a high-income economy problem, overweight children have become a growing concern in developing countries. Research shows an association between childhood obesity and a high prevalence of diabetes, respiratory disease, high blood pressure, and psychosocial and orthopedic disorders (de Onis and Blössner 2003). Childhood obesity is associated with a higher chance of obesity, premature death, and disability in adulthood. In addition to increased future risks, obese children experience breathing difficulties and increased risk of fractures, hypertension, early markers of cardiovascular disease, insulin resistance, and psychological effects. Children in low- and middle-income countries are more vulnerable to inadequate nutrition before birth and in infancy and early childhood. Many of these children are exposed to high-fat, high-sugar, high-salt, calorie-dense, micronutrient-poor foods, which tend be lower in cost than more nutritious foods. These dietary patterns, in conjunction with low levels of physical activity, result in sharp increases in childhood obesity, while under-nutrition continues. Estimates are modeled estimates produced by the JME. Primary data sources of the anthropometric measurements are national surveys. These surveys are administered sporadically, resulting in sparse data for many countries. Furthermore, the trend of the indicators over time is usually not a straight line and varies by country. Tracking the current level and progress of indicators helps determine if countries are on track to meet certain thresholds, such as those indicated in the SDGs. Thus the JME developed statistical models and produced the modeled estimates.

According to a survey conducted in India, the share of overweight or obese children in 2021 stood at *** percent. This was a significant increase compared to 2015. The rise in obesity among children under the age of five was seen across most states in India.

The prevalence of obesity among adults in India in 2022 reported an increase of around ***** percent of the entire population compared to 2012. Economic inequality, among other socio-economic determinants, is one of the major factors for the prevalence of obesity and malnutrition at the same time in India.

Historical dataset showing India obesity rate by year from N/A to N/A.

As per the results of a large scale survey in 2021, the Indian city of Indore had the highest share of people with normal levels of body mass index. Whereas, the city of Bhubaneshwar had the highest share of overweight respondents in the south Asian country.

In financial year 2016, approximately ** percent of urban adults in northern India were overweight. However, only about ** percent of adults in urban regions of central India were overweight during the same time period.

BackgroundFor women of reproductive age, overweight and obesity are an established risk factor for several medical complications. To address the increasing rate of obesity in India through public health awareness programs, the association between common behaviors and overweight and obesity needs to be investigated. This study aims to determine whether there is any association between the frequency of television watching and overweight and obesity among women of reproductive age (15–49 years) in India.MethodsThis is a cross-sectional study that utilized data from the National Family Health Survey (NFHS-4), which utilized a nationally representative sample from all 29 states and 7 union territories of India. The survey itself followed a two-staged stratified random sampling technique. The primary outcome of interest was overweight (23.0 kg/m2 to

In financial year 2012, about eight percent of rural adults in southern India suffered from being obesity. However, only about *** percent of adults in rural regions of central India were obese that year.

The India weight loss supplements market is projected to expand at a CAGR of 20.20% through 2034 due to rising obesity rate, rapid urbanization and product innovations.

India is facing a steep rise in obesity, driven by urban lifestyles, stress, and poor dietary habits. According to The Lancet, nearly 44.9 crore Indians will be obese by 2050, significantly heightening risks of Type 2 diabetes, cardiovascular diseases, and metabolic disorders. In response, companies are innovating weight loss supplements tailored to these growing health challenges. For instance, Veera Health launched “Sculpt” in February 2025, a GLP-1 boosting, plant-based supplement designed to enhance metabolism, curb appetite, and improve insulin sensitivity, addressing obesity and diabetes simultaneously.

The India weight loss supplements market is getting regulated and organized. Bodies, such as FSSAI (Food Safety and Standards Authority of India) have established better guidelines for health supplements and nutraceuticals, enhancing consumer confidence. In 2022, FSSAI mandated stricter labelling norms and ingredient disclosures for all health supplements, including weight loss products, to ensure transparency and consumer safety. With the industry organized, multinationals are establishing in the Indian market, with high-tech formulations and tighter quality standards.

A notable example is Himalaya Wellness, which has developed its AyurSlim capsules in full compliance with FSSAI’s 2022 labelling and ingredient disclosure norms. The product clearly lists herbal actives such as Garcinia, Gymnema, and Guggul, adhering to transparency and safety standards. This alignment with FSSAI regulations reflects how established nutraceutical brands are adapting to India’s evolving regulatory framework while promoting scientifically validated, consumer-trusted weight management solutions.

Snapshot img

Weight Management Market Size 2025-2029

The weight management market size is forecast to increase by USD 114.79 billion at a CAGR of 10.9% between 2024 and 2029.

The market is driven by the growing obese population and rising demand for weight management services from developing economies. The increasing prevalence of obesity and related health issues globally presents a significant opportunity for market participants. However, marketing challenges associated with weight management products and services pose a significant hurdle. The stigma surrounding obesity and the perception that weight loss is a personal responsibility rather than a health issue create barriers to market penetration. Health insurance plays a pivotal role in covering costs, while fitness apps and mobile health apps enhance accessibility and tracking.
Companies seeking to capitalize on market opportunities must address these challenges through innovative marketing strategies, affordable pricing, and education initiatives to shift societal perceptions and increase accessibility to weight management services. By focusing on these areas, market participants can effectively navigate challenges and capitalize on the growing demand for weight management solutions. Innovative weight management solutions include waistline control, fitness equipment, surgical equipment, healthy dietary choices, and lifestyle changes.

What will be the Size of the Weight Management Market during the forecast period?

Explore in-depth regional segment analysis with market size data - historical 2019-2023 and forecasts 2025-2029 - in the full report.
Request Free Sample

The market for weight management solutions continues to evolve, reflecting the complex and multifaceted nature of weight management and its applications across various sectors. Sleeve gastrectomy and adjustable gastric banding are among the surgical interventions, while anti-obesity medications and pharmacological interventions offer alternative approaches. The prevalence of metabolic syndrome and its associated health risks, including cardiovascular disease and type 2 diabetes, underscores the urgency for sustainable weight loss solutions. Mindful eating, nutrition education, and meal planning are essential components of health behavior modification, while physical fitness and regular exercise routines contribute to weight regain prevention. Fitness and recreational sports centers are offering a wide range of HIIT classes, and HIIT fitness videos are flooding the market.

Hormonal imbalance and stress management are also crucial factors in weight management. The industry is expected to grow by 5.3% annually, driven by the increasing prevalence of obesity and related health issues. For instance, a study showed that patients who underwent bariatric surgery experienced an average weight loss of 30% within the first year. Social media and the young population's hectic lifestyles have led to increased fast food consumption and weight-related health issues, necessitating preventive measures and weight management programs. Additionally, the complexity and cost of weight management solutions can deter potential customers, particularly in developing economies with limited resources.

How is this Weight Management Industry segmented?

The weight management industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD million' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Type

  Diet
  Equipment
  Services


Distribution Channel

  Offline
  Online


End-user

  Fitness centers and health clubs
  Commercial weight loss centers
  Online weight loss programs
  Slimming centers
  Others


Geography

  North America

    US
    Canada


  Europe

    France
    Germany
    Italy
    UK


  APAC

    China
    India
    Japan
    South Korea


  Rest of World (ROW)

By Type Insights

The Diet segment is estimated to witness significant growth during the forecast period. The market is driven by the growing concern over health issues related to visceral fat, weight fluctuation, and obesity. Obesity, characterized by a body mass index (BMI) of 30 or higher, affects over one-third of the global population. This condition can lead to various health complications, including high blood pressure, joint problems, diabetes, and insulin sensitivity issues. To combat these health concerns, weight loss programs focusing on calorie expenditure through diet and physical activity have gained popularity. Diets, specifically, dominate the market, as they offer a more sustainable approach to weight management. Nutritional counseling and micronutrient intake are essential components of effective weight loss programs, ensuring a balanced macronutrient and micronutrient intake. Obesity rates continue to rise, fueling the demand for

Descriptive statistics by overweight or obesity status.

MC4R Agonists for Obesity Market Outlook

According to our latest research, the Global MC4R Agonists for Obesity market size was valued at $1.2 billion in 2024 and is projected to reach $7.8 billion by 2033, expanding at a CAGR of 23.6% during the forecast period of 2025–2033. The primary driver accelerating this robust market growth is the rising prevalence of obesity worldwide, coupled with the urgent need for targeted therapies that address underlying genetic and metabolic causes. The increasing recognition of melanocortin-4 receptor (MC4R) pathway dysfunction in various forms of obesity, including monogenic and syndromic types, has propelled research and commercial interest in MC4R agonists. With a growing pipeline of novel drug candidates and the recent regulatory approvals of first-in-class therapies, the market is poised for significant expansion, especially as healthcare systems globally shift toward precision medicine approaches for complex metabolic disorders.

Regional Outlook

North America currently dominates the MC4R Agonists for Obesity market, accounting for the largest market share of over 45% in 2024. This region’s leadership can be attributed to a combination of factors including a mature pharmaceutical landscape, high obesity prevalence (with the United States reporting adult obesity rates exceeding 40%), and strong healthcare infrastructure supporting advanced therapeutic adoption. Moreover, North America benefits from robust regulatory frameworks that have enabled the early approval and commercialization of breakthrough MC4R agonists such as setmelanotide. The presence of leading biopharmaceutical companies and active academic research collaborations further bolster the region’s innovation ecosystem, driving both clinical development and patient access. The region’s reimbursement policies and proactive patient advocacy groups also contribute to rapid uptake and sustained market growth.

The Asia Pacific region is forecasted to be the fastest-growing market, with a projected CAGR of 28.9% from 2025 to 2033. This exceptional growth trajectory is fueled by escalating rates of obesity in populous countries such as China and India, where lifestyle changes and urbanization have markedly increased metabolic disease burdens. Governments and private sector stakeholders are ramping up investments in healthcare infrastructure, clinical trials, and public awareness campaigns targeting obesity and its complications. Additionally, the expanding network of specialty clinics and the rise of telemedicine platforms are improving diagnosis and treatment accessibility for rare genetic obesity disorders. Pharmaceutical companies are increasingly targeting Asia Pacific for clinical development and commercialization partnerships, recognizing the region’s large, underpenetrated patient pool and evolving regulatory landscape that is becoming more supportive of novel therapies.

Emerging economies in Latin America and the Middle East & Africa are gradually entering the MC4R Agonists for Obesity market but face unique adoption challenges. In these regions, limited healthcare budgets, lower awareness of genetic obesity subtypes, and fragmented healthcare delivery systems impede rapid market penetration. However, there is growing localized demand driven by rising obesity rates and gradual improvements in diagnostic capabilities. Policy reforms aimed at combating non-communicable diseases, coupled with international collaborations for clinical trials and drug access programs, are beginning to create pathways for market entry. Over time, as regulatory harmonization and healthcare infrastructure improve, these markets are expected to witness increased uptake of MC4R agonists, albeit at a slower pace compared to developed regions.

Report Scope

As per the results of a large scale survey in 2021, about ** percent of teens below the age of 19 years were found to be underweight due to the lack of right nutrition intake. On the other hand, a majority of the respondents above ** were overweight or obese.

Gastric Electrical Stimulation for Obesity Devices Market Outlook

According to our latest research, the Global Gastric Electrical Stimulation for Obesity Devices market size was valued at $312 million in 2024 and is projected to reach $1.12 billion by 2033, expanding at a CAGR of 15.2% during 2024–2033. The primary factor propelling the robust growth of this market is the rising global prevalence of obesity and overweight conditions, which has prompted increased demand for minimally invasive and effective obesity management solutions. As public health authorities and healthcare providers intensify their focus on combating obesity-related comorbidities, gastric electrical stimulation (GES) devices have emerged as a promising alternative to traditional bariatric surgery, offering a less invasive approach with fewer complications and faster recovery times. This shift is further supported by ongoing technological advancements, which have enhanced device efficacy and patient outcomes, thereby making GES devices an increasingly attractive option for both patients and clinicians worldwide.

Regional Outlook

North America currently holds the largest share of the Gastric Electrical Stimulation for Obesity Devices market, accounting for over 42% of global revenue in 2024. This dominance is primarily attributed to the region’s mature healthcare infrastructure, high obesity rates, and early adoption of innovative medical technologies. The United States, in particular, benefits from favorable reimbursement policies, a strong presence of leading device manufacturers, and a high level of awareness among healthcare professionals and patients regarding the benefits of gastric electrical stimulation. Additionally, North America’s regulatory environment, while stringent, has paved the way for the approval and commercialization of advanced GES devices, further solidifying its leadership in the global market. The region’s established clinical research ecosystem and ongoing investments in obesity management programs are expected to sustain its market supremacy over the forecast period.

The Asia Pacific region is anticipated to witness the fastest growth in the Gastric Electrical Stimulation for Obesity Devices market, with a projected CAGR of 18.9% from 2024 to 2033. This rapid expansion is driven by rising obesity rates in countries such as China, India, and Japan, coupled with increasing healthcare expenditure and growing awareness of minimally invasive weight loss solutions. Governments across the region are launching initiatives to combat obesity and related metabolic disorders, which is fueling demand for advanced therapeutic options like GES devices. Furthermore, the entry of international medical device manufacturers and the establishment of local production facilities are enhancing accessibility and affordability of these devices. The growing number of specialized obesity treatment centers and the expansion of private healthcare infrastructure are additional factors contributing to the region’s remarkable market growth.

Emerging economies in Latin America, the Middle East, and Africa are gradually adopting gastric electrical stimulation for obesity, though market penetration remains comparatively low. These regions face unique challenges, including limited healthcare infrastructure, lower disposable incomes, and a lack of trained specialists to perform GES procedures. However, increasing urbanization, changing dietary habits, and a rise in obesity prevalence are generating localized demand for effective weight management solutions. Policy reforms aimed at improving healthcare access, along with international collaborations to build capacity and awareness, are expected to drive gradual market adoption. Nevertheless, affordability and regulatory hurdles continue to be significant barriers, necessitating tailored strategies by device manufacturers to unlock the full potential of these emerging markets.

Report Scope

Medical Bariatric Hospital Bed Market Outlook

The global medical bariatric hospital bed market size was valued at approximately USD 1.2 billion in 2023 and is projected to reach around USD 2.5 billion by 2032, growing at a CAGR of about 8.3% during the forecast period. The increasing prevalence of obesity and related comorbidities is a significant growth factor driving the demand for bariatric hospital beds globally. As healthcare providers aim to accommodate the special needs of bariatric patients, the market for bariatric hospital beds is experiencing substantial growth.

One of the primary growth factors for this market is the rising incidence of obesity worldwide. According to the World Health Organization, global obesity rates have nearly tripled since 1975, with more than 1.9 billion adults classified as overweight in 2023. This surge in obesity rates has led to an increased demand for specialized hospital equipment, including bariatric beds, designed to support the higher weight capacities required for obese patients. Bariatric beds are not only larger but also incorporate advanced features to ensure patient comfort and safety, further driving their adoption in healthcare facilities.

Technological advancements in medical bariatric hospital beds are another key driver of market growth. Innovations such as fully electric beds, integrated patient monitoring systems, and enhanced mobility features are making these beds more functional and user-friendly. Fully electric bariatric beds, for instance, allow for smoother and more precise adjustments, improving patient comfort and easing the workload for healthcare providers. Additionally, the integration of smart technologies that enable remote patient monitoring and data collection has made these beds highly sought after in modern healthcare settings.

The growing awareness and focus on patient-centric care are also contributing to the market expansion. Healthcare providers are increasingly recognizing the importance of providing tailored care for obese patients, who often require special accommodations to ensure their safety and comfort. This shift towards patient-centric care is driving investments in bariatric hospital beds equipped with advanced features such as automated pressure relief systems and ergonomic designs that help prevent complications like pressure ulcers and respiratory issues among bariatric patients.

Regionally, North America holds the largest share of the medical bariatric hospital bed market, owing to the high prevalence of obesity and well-established healthcare infrastructure. The United States, in particular, is a significant contributor to market growth, with its advanced medical facilities and high healthcare expenditure. Europe follows closely, with countries like the UK, Germany, and France investing heavily in healthcare technologies. The Asia Pacific region is expected to witness the fastest growth during the forecast period, driven by rising healthcare investments and increasing obesity rates in countries like India and China.

Product Type Analysis

The medical bariatric hospital bed market is segmented by product type into manual bariatric beds, semi-electric bariatric beds, and fully electric bariatric beds. Manual bariatric beds are the most basic type, offering simple mechanical adjustments without electrical components. These beds are traditionally more affordable and are commonly used in settings where budget constraints are a significant concern. Despite their lower cost, manual bariatric beds are designed to provide robust support and durability, handling the higher weight capacities required for bariatric patients.

Semi-electric bariatric beds represent a middle-ground option, combining manual and electric adjustment features. These beds typically allow for electric adjustments of the head and foot sections while the height adjustment remains manual. This hybrid approach offers a balance between functionality and cost, making semi-electric bariatric beds popular in a variety of healthcare settings, including small hospitals and home care environments. The ability to electrically adjust key sections of the bed enhances patient comfort and reduces the physical strain on caregivers.

Fully electric bariatric beds are the most advanced and feature-rich option in this segment. These beds offer complete electric adjustability, including height, head, and foot sectio

ObjectiveTo estimate the global and country-level burden of overweight and obesity among pregnant women from 2005 to 2014.MethodsPublicly accessible country-level data were collected from the World Health Organization, the World Bank and the Food and Agricultural Organization. We estimated the number of overweight and obese pregnant women among 184 countries and determined the time-related trend from 2005 to 2014. Based on panel data model, we determined the effects of food energy supply, urbanization, gross national income and female employment on the number of overweight and obese pregnant women.ResultsWe estimated that 38.9 million overweight and obese pregnant women and 14.6 million obese pregnant women existed globally in 2014. In upper middle income countries and lower middle income countries, there were sharp increases in the number of overweight and obese pregnant women. In 2014, the percentage of female with overweight and obesity in India was 21.7%, and India had the largest number of overweight and obese pregnant women (4.3 million), which accounted for 11.1% in the world. In the United States of America, a third of women were obese, and the number of obese pregnant women was 1.1 million. In high income countries, caloric supply and urbanization were positively associated with the number of overweight and obese pregnant women. The percentage of employment in agriculture was inversely associated with the number of overweight and obese pregnant women, but only in upper middle income countries and lower middle income countries.ConclusionThe number of overweight and obese pregnant women has increased in high income and middle income countries. Environmental changes could lead to increased caloric supply and decreased energy expenditure among women. National and local governments should work together to create a healthy food environment.

In financial year 2016, about ** percent of urban adults in northern India suffered from abdominal obesity. However, only about ** percent of adults in urban regions of central India suffered from that disease that year.

India Bariatric Surgery Market size was valued at USD 300 Million in 2024 and is projected to reach USD 750 Million by 2031, growing at a CAGR of 14.7% from 2024 to 2031.

India Bariatric Surgery Market Drivers

Rising Obesity Rates: The increasing prevalence of obesity and related health issues is driving the demand for bariatric surgery. Technological Advancements: Advances in surgical techniques and technologies have made bariatric surgery safer and more effective. Changing Lifestyle and Dietary Habits: The adoption of sedentary lifestyles and unhealthy eating habits is contributing to obesity and the need for weight loss surgery.

India Bariatric Surgery Market Restraints

High Cost: Bariatric surgery can be expensive, limiting its accessibility to a significant portion of the population. Lack of Insurance Coverage: Limited insurance coverage for weight loss surgery can hinder patient affordability. Skill Shortages: A shortage of skilled surgeons and healthcare professionals can constrain the availability of bariatric surgery services.

The FDA-approved weight-loss device market is experiencing robust growth, driven by the increasing prevalence of obesity and related comorbidities globally. The market, estimated at $2.5 billion in 2025, is projected to achieve a compound annual growth rate (CAGR) of 15% from 2025 to 2033, reaching an estimated $8 billion by 2033. Several factors contribute to this expansion. Technological advancements in minimally invasive procedures, such as gastric balloons and electrical stimulation systems, are making weight-loss solutions more accessible and less invasive. Rising healthcare expenditure, coupled with increased awareness of obesity's health risks, fuels demand for effective and safe weight-management interventions. Furthermore, the growing preference for outpatient procedures and shorter recovery times contributes to the market's attractiveness. The market is segmented by application (hospital, clinic, household) and device type (gastric band, electrical stimulation, gastric balloon, gastric emptying systems, and others). North America currently holds the largest market share due to high obesity rates and advanced healthcare infrastructure, followed by Europe and Asia Pacific, which are expected to witness significant growth due to increasing disposable incomes and rising awareness. However, high costs associated with these devices and potential side effects pose challenges to market growth. Competition among established players like ReShape Medical, Allurion, and Apollo Endosurgery, and the entry of new players, will further shape the market dynamics. Regulatory approvals and the ongoing development of innovative technologies will be crucial in shaping the future trajectory of this rapidly expanding market. The market segmentation reveals significant opportunities across diverse applications and device types. Hospitals and clinics constitute the largest application segment, driven by the need for medically supervised procedures. However, the household segment is projected to experience rapid growth as individuals increasingly seek at-home weight management options. Within device types, gastric balloon systems are gaining traction due to their minimally invasive nature and relatively shorter recovery periods. Electrical stimulation systems also hold significant promise due to their potential for long-term weight management, although they are currently in earlier stages of market penetration. Geographical distribution highlights the North American dominance, reflecting the region's advanced medical infrastructure and high obesity rates. However, the emerging markets in Asia Pacific, particularly in India and China, represent significant future growth potential as disposable incomes rise and awareness of obesity-related health issues increases. Companies are actively pursuing strategic partnerships and product innovations to capitalize on these opportunities and improve access to FDA-approved weight-loss solutions globally.